Showing results (591-600 of 754) with videos related to

Sort By:
Pageof 76
British Journal of Clinical Pharmacology|May 31, 2019
Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantationM Y E C van der Stoep, J Zwaveling, A Bertaina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblingsM Zecca, A Pession, C Messina, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 24, 2011
Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxisA Busca, I Cavecchia, F Locatelli, et al.
Neurology|March 15, 2006
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutationR Del Bo, F Locatelli, S Corti, et al.
Blood|March 15, 1996
Mutations in the erythropoietin receptor gene are not a common cause of Diamond-Blackfan anemiaI Dianzani, E Garelli, C Dompè, et al.
Anticancer Research|July 1, 1996
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)I Buggia, M Zecca, E P Alessandrino, et al.
Clinical Nephrology|February 5, 2010
C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney diseaseF Locatelli, J F E Mann, J C Aldigier, et al.
Haematologica|April 29, 1998
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrowW Arcese, F Aversa, G Bandini, et al.
Genes, Chromosomes & Cancer|October 1, 1996
Constitutional trisomy 8 as first mutation in multistep carcinogenesis: clinical, cytogenetic, and molecular data on three casesL Seghezzi, E Maserati, A Minelli, et al.
Bone Marrow Transplantation|January 1, 1996
Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemiaF Locatelli, A Pession, M Zecca, et al.
Pageof 76